BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2319515)

  • 21. Comparison of ticarcillin plus clavulanic acid with clindamycin and gentamicin in the treatment of postcesarean endomyometritis.
    Apuzzio JJ; Ganesh V; Kaminski Z; Bergen B; Holland B; Louria DB
    Surg Gynecol Obstet; 1988 May; 166(5):413-7. PubMed ID: 3259017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticarcillin/clavulanate for treatment of postpartum endometritis.
    Faro S; Hammill HA; Maccato M; Martens M
    Rev Infect Dis; 1991; 13 Suppl 9():S758-62. PubMed ID: 1925321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticarcillin plus clavulanic acid (Timentin)--further UK trial results.
    Tehan S; Horobin J; Gordonsmith R; McLatchie GR
    Br J Clin Pract; 1988 Jan; 42(1):8-16. PubMed ID: 3058192
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of pelvioperitonitis and Douglas' abscess].
    Matsuda S; Suzuki M; Miyazaki R; Cho N; Kunii K; Fukunaga K; Hayashi S; Nakamura H; Tateno M; Okada H
    Jpn J Antibiot; 1987 May; 40(5):951-68. PubMed ID: 3499526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic evaluation of the ticarcillin-clavulanic acid combination in severe nephrourologic infections.
    Dalet F; Torrellas A; Del Rio G
    Chemioterapia; 1987 Jun; 6(2 Suppl):512-3. PubMed ID: 3509486
    [No Abstract]   [Full Text] [Related]  

  • 26. A preliminary report of ticarcillin and clavulanate versus triple antibiotic therapy in children with ruptured appendicitis.
    Pokorny WJ; Kaplan SL; Mason EO
    Surg Gynecol Obstet; 1991; 172 Suppl():54-6. PubMed ID: 2024227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ticarcillin/clavulanate potassium in the treatment of obstetric and gynecologic infections.
    Martens MG
    Hosp Formul; 1990 Feb; 25(2):186-8, 192. PubMed ID: 10113105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.
    Fink MP; Helsmoortel CM; Arous EJ; Doern GV; Moriarty KP; Fairchild PG; Townsend PL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():147-56. PubMed ID: 2691476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
    Judlin P; Koebele A; Zaccabri A; van Walleghen E; Pavis A; Badonnel Y; Dailloux M; Landes P
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):253-9. PubMed ID: 7622771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticarcillin/clavulanate in severe infections in patients with varying renal function.
    Dalet F; del Rio G; Torrellas A
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():131-9. PubMed ID: 2606815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM; Tan JS
    Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
    Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections.
    Gunning JE
    Surg Gynecol Obstet; 1986 Aug; 163(2):156-62. PubMed ID: 3526592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clindamycin in the treatment of obstetric and gynecologic infections: a review.
    Zambrano D
    Clin Ther; 1991; 13(1):58-80. PubMed ID: 2029726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
    Larsen JW; Voise CT; Grossman JH
    Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experience with Timentin].
    Vacek V; Benes J; Kabelková M
    Cas Lek Cesk; 1997 Dec; 136(24):764-7. PubMed ID: 9511261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
    Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
    Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.